A roundtable convened by the Reagan-Udall Foundation for the FDA developed recommendations for oncology multi-regional clinical trials (MRCTs). The roundtable included representatives of the biopharmaceutical industry, oncology clinical trial sites, clinical research organizations, and cancer-focused non-profits. “A common thread underscoring each recommendation is the import... Read More